Secondary Outcomes
anxiety, anhedonia, depressive symptoms
ADVERSE EVENTS

Alcohol consumption (i.e. proportion of abstinent days, proportion of heavy drinking days, mean daily alcohol use) during the 6 months after randomization (blinded phase) and the following 12 months (unblinded ON phase).Alcohol craving, depressive symptoms, anhedonia, anxiety, quality of life, and global functioning at months 6 and 18 after randomization.Safety was assessed by means of occurrence of any adverse or serios adverse events throughout the 18-month study period.